Hippocampal volume in geriatric depression

Biological Psychiatry

Volumn 48, Issue 4, 2000, Pages 301-309

  Steffens, David C ^a   Byrum, Christopher E ^a   McQuoid, Douglas R ^a   Greenberg, Daniel L ^a   Payne, Martha E ^a   Blitchington, Timothy F ^b   MacFall, James R ^a   Krishnan, K Ranga Rama ^a  

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

^b Duke Univ Med Ctr ^*

Author keywords

Depression; Hippocampus; Magnetic resonance imaging

Indexed keywords

AGED; ARTICLE; BRAIN FUNCTION; BRAIN SIZE; COGNITION; COMORBIDITY; DEMENTIA; DEPRESSION; FEMALE; HIPPOCAMPUS; HUMAN; MAJOR CLINICAL STUDY; MALE; MENTAL DISEASE; NEUROLOGIC DISEASE; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL;

AGED; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HIPPOCAMPUS; HUMANS; MAGNETIC RESONANCE IMAGING; MALE; MIDDLE AGED; PSYCHIATRIC STATUS RATING SCALES;

EID: 0034663366     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-3223(00)00829-5     Document Type: Article

References (36)

1. Axelson D.A., Doraiswamy P.M., McDonald W.M., Boyko O.B., Tupler L.A., Patterson L.J., et al. Hypercortisolemia and hippocampal changes in depression. Psychiatry Res. 47:1993;163-173.
2. Byrum C.E., MacFall J.R., Charles H.C., Chitilla V.R., Boyko O.B., Upchurch L., et al. Accuracy and reproducibility of brain and tissue volumes using a magnetic resonance segmentation method. Psychiatry Res. 67:1996;215-234.
3. Carroll B.J., Feinberg M., Greden J.F., Tarika J., Albala A.A., Haskett R.F., et al. A specific laboratory test for the diagnosis of melancholia. Standardization, validation, and clinical utility. Arch Gen Psychiatry. 38:1981;15-22.
4. Carroll B.J., Feinberg M., Smouse P.E., Rawson S.G., Greden J.F. The Carroll Rating Scale for Depression. I. Development, reliability, and validation. Br J Psychiatry. 138:1981;194-200.
5. Coffey C.E., Weiner R.D., Djang W.T., Figiel G.S., Soady S.A., Patterson L.J., et al. Brain anatomic effects of electroconvulsive therapy. A prospective magnetic resonance imaging study. Arch Gen Psychiatry. 48:1991;1013-1021.
6. Coffey C.E., Wilkinson W.E., Weiner R.D., Parashos I.A., Djang W.T., Webb M.C., et al. Quantitative cerebral anatomy in depression. A controlled magnetic resonance imaging study. Arch Gen Psychiatry. 50:1993;7-16.
7. Endicott J., Spitzer R.L., Fleiss J.L., Cohen J. The Global Assessment Scale A procedure for measuring overall severity of psychiatric disturbance . Arch Gen Psychiatry. 33:1976;766-771.
8. Folstein M.F., Folstein S.E., McHugh P.R. "Mini-mental state." A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res. 12:1975;189-198.
9. George L.K., Blazer D.G., Hughes D.C., Fowler N. Social support and the outcome of major depression. Br J Psychiatry. 154:1989;478-485.
10. Hachinski V.C., Iliff L.D., Zilhka E., Du Boulay G.H., McAllister V.L., Marshall J., et al. Cerebral blood flow in dementia. Arch Neurol. 32:1975;632-637.
11. Hamilton M. A rating scale for depression. J Neurol Neurosurg Psychiatry. 23:1960;56-61.
12. Jack C.R. Jr, Petersen R.C., Xu Y.C., O'Brien P.C., Waring S.C., Tangalos E.G., et al. Hippocampal atrophy and apoli-poprotein E genotype are independently associated with Alzheimer's disease. Ann Neurol. 43:1998;303-310.
13. Jorm AF, van Duijn CM, Chandra V, Fratiglioni L, Graves AB, Heyman A, et al (1991): Psychiatric history and related exposures as risk factors for Alzheimer's disease: A collaborative re-analysis of case-control studies. Int J Epidemiol 20(suppl 2):S43-S47.
14. Kikinis R., Shenton M.E., Gerig G., Martin J., Anderson M., Metcalf D., et al. Routine quantitative analysis of brain and cerebrospinal fluid spaces with MR imaging. J Magn Reson Imaging. 2:1992;619-629.
15. Kokmen E., Beard C.M., Chandra V., Offord K.P., Schoenberg B.S., Ballard D.J. Clinical risk factors for Alzheimer's disease A population-based case-control study . Neurology. 41:1991;1393-1397.
16. Krishnan K.R., Doraiswamy P.M., Figiel G.S., Husain M.M., Shah S.A., Na C., et al. Hippocampal abnormalities in depression. J Neuropsychiatry Clin Neurosci. 3:1991;387-391.
17. Krishnan K.R., Hays J.C., Blazer D.G. MRI-defined vascular depression. Am J Psychiatry. 154:1997;497-501.
18. Krishnan K.R.R., Ritchie J.C. Jr, Tupler L.A., McDonald W.M., Knight D., Nemeroff C.B., et al. Apolipoprotein E epsilon 4. Neurology. 44:1994;2420-2421.
19. Laakso M.P., Soininen H., Partanen K., Lehtovirta M., Hallikainen M., Hanninen T., et al. MRI of the hippocampus in Alzheimer's disease sensitivity, specificity, and analysis of the incorrectly classified subjects . Neurobiol Aging. 19:1998;23-31.
20. Landerman R., George L.K., Campbell R.T., Blazer D.G. Alternative models of the stress buffering hypothesis. Am J Community Psychol. 17:1989;626-642.
21. Linn B.S., Linn M.W., Gurel L. Cumulative illness rating scale. J Am Geriatr Soc. 16:1968;622-626.
22. MacFall J.R., Byrum C.E., Parashos I., Early B., Charles H.C., Chittilla V., et al. Relative accuracy and reproducibility of regional MRI brain volumes for point-counting methods. Psychiatry Res. 55:1994;167-177.
23. McEwen B.S. Possible mechanisms for atrophy of the human hippocampus. Mol Psychiatry. 2:1997;255-262.
24. Mongeau R., Blier P., de Montigny C. The serotonergic and noradrenergic systems of the hippocampus Their interactions and the effects of antidepressant treatments . Brain Res Brain Res Rev. 23:1997;145-195.
25. Montgomery S.A., Asberg M. A new depression scale designed to be sensitive to change. Br J Psychiatry. 134:1979;382-389.
26. Morris J.C., Mohs R.C., Rogers H., Fillenbaum G., Heyman A. Consortium to Establish a Registry for Alzheimer's Disease (CERAD) clinical and neuropsychological assessment of Alzheimer's disease. Psychopharmacol Bull. 24:1988;641-652.
27. O'Brien J.T., Desmond P., Ames D., Schweitzer I., Chiu E., Tress B. Temporal lobe magnetic resonance imaging can differentiate Alzheimer's disease from normal ageing, depression, vascular dementia and other causes of cognitive impairment. Psychol Med. 27:1997;1267-1275.
28. Radloff L.S. The CES-D scale A self-report depression scale for research in the general population . Appl Psychol Measures. 1:1977;385-401.
29. Robins L.N., Helzer J.E., Croughan J., Ratcliff K.S. National Institute of Mental Health Diagnostic Interview Schedule Its history, characteristics, and validity . Arch Gen Psychiatry. 38:1981;381-389.
30. Sapolsky R.M. Potential behavioral modification of glucocorticoid damage to the hippocampus. Behav Brain Res. 57:1993;175-182.
31. Sheline Y.I. Hippocampal atrophy in major depression A result of depression-induced neurotoxicity . Mol Psychiatry. 1:1996;298-299.
32. Sheline Y.I., Wang P.W., Gado M.H., Csernansky J.G., Vannier M.W. Hippocampal atrophy in recurrent major depression. Proc Natl Acad Sci U S A. 93:1996;3908-3913.
33. Soares J.C., Mann J.J. The anatomy of mood disorders - review of structural neuroimaging studies. Biol Psychiatry. 41:1997;86-106.
34. Speck C.E., Kukull W.A., Brenner D.E., Bowen J.D., McCormick W.C., Teri L., et al. History of depression as a risk factor for Alzheimer's disease. Epidemiology. 6:1995;366-369.
35. Spitzer R.L. Psychiatric diagnosis Are clinicians still necessary? Compr Psychiatry. 24:1983;399-411.
36. Steffens D.C., Plassman B.L., Helms M.J., Welsh-Bohmer K.A., Saunders A.M., Breitner J.C. A twin study of late-onset depression and apolipoprotein E epsilon 4 as risk factors for Alzheimer's disease. Biol Psychiatry. 41:1997;851-856.